Medtech Innovator is located in Los Angeles, CA. The organization was established in 2019. According to its NTEE Classification (B90) the organization is classified as: Educational Services, under the broad grouping of Education and related organizations. As of 06/2021, Medtech Innovator employed 15 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Medtech Innovator is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Medtech Innovator generated $4.6m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 48.3% each year . All expenses for the organization totaled $2.4m during the year ending 06/2021. While expenses have increased by 4.2% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Medtech Innovator has awarded 32 individual grants totaling $3,330,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
MEDTECH INNOVATOR ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MEDTECH INNOVATOR ("MTI") ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. ITS MISSION IS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. WHILE MANY ENTITIES EXIST THAT PROVIDE EARLY-STAGE SUPPORT FOR HEALTH CARE INNOVATION, THESE ORGANIZATIONS COMMONLY ARE REGIONALLY-BASED AND LIMITED BY THE FINANCIAL RESOURCES AND EXPERTISE OF THEIR LOCAL ECOSYSTEMS. AS A RESULT, PROMISING MEDICAL INNOVATIONS RECEIVE EARLY SUPPORT BUT ULTIMATELY FAIL TO REACH PATIENTS. MTI HAS BEEN PURPOSE-BUILT TO IDENTIFY THE MOST VIABLE STARTUPS AND IMMERSE THEM IN THE BEST VIRTUAL MEDTECH ECOSYSTEM IN THE WORLD, NO MATTER WHERE THEY ARE BASED. MTI PROVIDES A RESOURCE-RICH ENVIRONMENT TO ASSIST STARTUPS IN HONING THEIR BUSINESS MODELS, DEVELOPING THEIR VALUE PROPOSITIONS, AND SECURING THEIR NEXT ROUND OF FUNDING, AMONG OTHER CHALLENGES FACED BY COMPANIES ATTEMPTING TO COMMERCIALIZE INNOVATIVE HEALTH TECHNOLOGY FOR THE BENEFIT OF PATIENTS AROUND THE WORLD. IN 2021, MTI LAUNCHED BIOTOOLS INNOVATOR, A NEW INITIATIVE THAT LEVERAGES ITS SUCCESSFUL MODEL TO SUPPORT INNOVATORS IN THE LIFE SCIENCE TOOLS AND DIAGNOSTICS SPACES. 1. MTI UNDERTAKES TWO PRIMARY ACTIVITIES: SECTOR/REGIONAL-BASED COMPETITIONS FOR INNOVATIVE STARTUPS AND A FOUR-MONTH MENTORSHIP-DRIVEN ACCELERATOR FOR THE LEADING APPLICANTS. EACH YEAR, MTI GIVES OUT A COMBINATION OF CASH PRIZES AND IN-KIND AWARDS THROUGH ITS VARIOUS COMPETITIONS, WHICH INCLUDE SEVERAL ROUNDS DURING WHICH THOUSANDS APPLY AND HUNDREDS OF COMPANIES GAIN INCREASING AMOUNTS OF EXPOSURE TO INDUSTRY LEADERS THROUGH ONLINE APPLICATION REVIEWS, IN-PERSON AND VIRTUAL PITCH EVENTS, AND AUDIENCE-DRIVEN, PUBLIC COMPETITIONS IN PARTNERSHIP WITH LEADING INDUSTRY CONFERENCES. AS THE COMPETITION PROGRESSES, COMPANIES ARE ACCEPTED INTO THE ANNUAL COHORT. THESE STARTUPS GAIN CRITICAL INDUSTRY-WIDE VISIBILITY AND ACCESS TO LEADING INVESTORS, MANUFACTURERS, PROVIDERS, AND CUSTOMERS. AMONG MANY BENEFITS, THEY RECEIVE EXCLUSIVE NETWORKING OPPORTUNITIES, INTERACTIVE WORKSHOPS, AND COACHING. THE COMPANIES ALSO HAVE MULTIPLE OCCASIONS TO SHOWCASE THEIR PRODUCTS AND GAIN EXPERIENCE PITCHING TO AUDIENCES OF INDUSTRY STAKEHOLDERS AND DECISION-MAKERS. A SUBSET OF EARLIER-STAGE COMPANIES TAKE PART IN A CUSTOMIZED MENTORSHIP PROGRAM WHERE THEY ARE PAIRED WITH SENIOR LEADERS IN THE MEDICAL TECHNOLOGY (MEDTECH) INDUSTRY. ALL COHORT COMPANIES HAVE THE OPPORTUNITY TO COMPETE FOR CASH PRIZES AND IN-KIND AWARDS, WITH THE LARGEST CASH AWARDS RESERVED FOR THE EARLIER-STAGE COHORT WHERE THESE NON-DILUTIVE FINANCIAL RESOURCES CAN HAVE A SIGNIFICANT IMPACT.2. MTI HAS ATTRACTED TOP TALENT TO OVERSEE THE COMPETITION AND ACCELERATOR PROGRAMS, INCLUDING STAFF MEMBERS WITH ADVANCED DEGREES AND DOCTORATES IN FIELDS OF STUDY RELEVANT TO THE STARTUP COMPANIES THEY ASSIST. MTI STAFFERS HAVE A BROAD KNOWLEDGE AND UNDERSTANDING OF THE MEDICAL TECHNOLOGY AND LIFE SCIENCES INDUSTRIES, INCLUDING THE REGULATORY AND REIMBURSEMENT REQUIREMENTS, THE INVESTMENT ENVIRONMENT, AND THE CLINICAL AND SCIENTIFIC NEEDS FOR RESEARCH AND DEVELOPMENT. MTI ALSO DEVELOPS RELATIONSHIPS WITH HUNDREDS OF INDUSTRY EXECUTIVES, HEALTH CARE PROVIDERS, INVESTORS AND KEY OPINION LEADERS, FOR THE BENEFIT OF COMPANIES PARTICIPATING IN ITS COMPETITION AND ACCELERATOR. MTI BRINGS THESE EXPERTS TOGETHER TO SERVE AS APPLICATION REVIEWERS AND JUDGES AT REGIONAL PITCH EVENTS AND COMPETITIONS, AND THEY OFFER FEEDBACK, GUIDANCE AND MENTORSHIP TO COMPANIES THAT PROGRESS THROUGH THE PROGRAM. THESE EXPERTS VOLUNTEER THEIR TIME TO SUPPORT MTI IN ITS MISSION TO IMPROVE THE LIVES OF PATIENTS.3. THE EVENTS OF THE COMPETITION ARE CONDUCTED THROUGHOUT THE YEAR, WITH APPLICATIONS OPENING IN OCTOBER OF THE PRECEDING YEAR. THE ACCELERATOR PROGRAMS TYPICALLY RUN FROM JUNE THROUGH OCTOBER.4. THE EVENTS OF THE COMPETITION AND ACCELERATOR TAKE PLACE VIRTUALLY AND IN CITIES AROUND THE UNITED STATES, SUCH AS SAN FRANCISCO, LOS ANGELES, SAN DIEGO, RESEARCH TRIANGLE PARK, SEATTLE, CHICAGO, HOUSTON, BOSTON, MINNEAPOLIS, PHILADELPHIA, AND WASHINGTON, D.C., AND IN INTERNATIONAL LOCATIONS SUCH AS IRELAND, ISRAEL, CANADA, JAPAN, AUSTRALIA, CHINA, AND SINGAPORE. THE ACCELERATOR IS A VIRTUAL PROGRAM, LARGELY CONDUCTED VIA WEBINAR AND TELECONFERENCE, IN ADDITION TO MULTI-DAY, IN-PERSON EVENTS HELD AT ITS BEGINNING AND CONCLUSION. ALL OF THE COMPANIES SELECTED FOR MEDTECH INNOVATOR'S ANNUAL COHORT PARTICIPATE IN THE SUMMIT AND FINALS, WHICH BRING TOGETHER SENIOR LEADERSHIP FROM EACH COMPANY ALONG WITH REPRESENTATIVES FROM MEDTECH INNOVATOR'S CORPORATE PARTNERS, REPRESENTATIVES FROM FEDERAL AGENCIES THAT SUPPORT MEDICAL INNOVATION SUCH AS FDA, HHS, DOD, AND NIH, AND KEY STAKEHOLDERS SUCH AS INVESTORS AND HEALTH CARE PROVIDERS.5. MTI SEEKS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF STARTUP COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. THIS WILL BE ACCOMPLISHED BY OFFERING SUBSTANTIVE RESOURCES AND NETWORK CONNECTIONS TO THE STARTUPS LEADING UP TO AND DURING THE ACCELERATOR AS WELL AS PROVIDING DIRECT FUNDING TO SELECT COMPANIES THROUGH AWARDS IN THE COMPETITION. MTI'S ACTIVITIES FURTHER THE PUBLIC GOOD BY UNITING LEADING STAKEHOLDERS IN THE MEDTECH INNOVATION ECOSYSTEM TO SUPPORT AND GUIDE TRANSFORMATIVE EARLY-STAGE COMPANIES THAT ARE STRIVING TO SOLVE UNMET PATIENT NEEDS AND INCREASE EFFICIENCY, QUALITY, EQUITY AND VALUE IN THE HEALTH CARE SYSTEM.6. MTI IS FUNDED BY CORPORATE INDUSTRY DONORS, INCLUDING LEADING MANUFACTURERS, PRIVATE FOUNDATIONS, INVESTORS, SERVICE PROVIDERS, STATE AND FEDERAL TRADE ASSOCIATIONS, AND GRANTS FROM GOVERNMENTAL AGENCIES. MTI HOPES TO INCREASE FINANCIAL SUPPORT FROM GOVERNMENTAL AGENCIES AND PRIVATE FOUNDATIONS THAT SUPPORT HEALTH CARE INNOVATION, AS MTI PROVIDES A UNIQUE FRAMEWORK TO HELP ENSURE THAT IMPORTANT GRANT-SUPPORTED HEALTH CARE TECHNOLOGIES ACTUALLY REACH PATIENTS IN NEED.7. THERE CURRENTLY ARE NO DBAS. MTI'S WEBSITE IS HTTPS://MEDTECHINNOVATOR.ORG.
MEDTECH INNOVATOR ("MTI") ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. ITS MISSION IS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. WHILE MANY ENTITIES EXIST THAT PROVIDE EARLY-STAGE SUPPORT FOR HEALTH CARE INNOVATION, THESE ORGANIZATIONS COMMONLY ARE REGIONALLY-BASED AND LIMITED BY THE FINANCIAL RESOURCES AND EXPERTISE OF THEIR LOCAL ECOSYSTEMS. AS A RESULT, PROMISING MEDICAL INNOVATIONS RECEIVE EARLY SUPPORT BUT ULTIMATELY FAIL TO REACH PATIENTS. MTI HAS BEEN PURPOSE-BUILT TO IDENTIFY THE MOST VIABLE STARTUPS AND IMMERSE THEM IN THE BEST VIRTUAL MEDTECH ECOSYSTEM IN THE WORLD, NO MATTER WHERE THEY ARE BASED. MTI PROVIDES A RESOURCE-RICH ENVIRONMENT TO ASSIST STARTUPS IN HONING THEIR BUSINESS MODELS, DEVELOPING THEIR VALUE PROPOSITIONS, AND SECURING THEIR NEXT ROUND OF FUNDING, AMONG OTHER CHALLENGES FACED BY COMPANIES ATTEMPTING TO COMMERCIALIZE INNOVATIVE HEALTH TECHNOLOGY FOR THE BENEFIT OF PATIENTS AROUND THE WORLD. IN 2021, MTI LAUNCHED BIOTOOLS INNOVATOR, A NEW INITIATIVE THAT LEVERAGES ITS SUCCESSFUL MODEL TO SUPPORT INNOVATORS IN THE LIFE SCIENCE TOOLS AND DIAGNOSTICS SPACES. 1. MTI UNDERTAKES TWO PRIMARY ACTIVITIES: SECTOR/REGIONAL-BASED COMPETITIONS FOR INNOVATIVE STARTUPS AND A FOUR-MONTH MENTORSHIP-DRIVEN ACCELERATOR FOR THE LEADING APPLICANTS. EACH YEAR, MTI GIVES OUT A COMBINATION OF CASH PRIZES AND IN-KIND AWARDS THROUGH ITS VARIOUS COMPETITIONS, WHICH INCLUDE SEVERAL ROUNDS DURING WHICH THOUSANDS APPLY AND HUNDREDS OF COMPANIES GAIN INCREASING AMOUNTS OF EXPOSURE TO INDUSTRY LEADERS THROUGH ONLINE APPLICATION REVIEWS, IN-PERSON AND VIRTUAL PITCH EVENTS, AND AUDIENCE-DRIVEN, PUBLIC COMPETITIONS IN PARTNERSHIP WITH LEADING INDUSTRY CONFERENCES. AS THE COMPETITION PROGRESSES, COMPANIES ARE ACCEPTED INTO THE ANNUAL COHORT. THESE STARTUPS GAIN CRITICAL INDUSTRY-WIDE VISIBILITY AND ACCESS TO LEADING INVESTORS, MANUFACTURERS, PROVIDERS, AND CUSTOMERS. AMONG MANY BENEFITS, THEY RECEIVE EXCLUSIVE NETWORKING OPPORTUNITIES, INTERACTIVE WORKSHOPS, AND COACHING. THE COMPANIES ALSO HAVE MULTIPLE OCCASIONS TO SHOWCASE THEIR PRODUCTS AND GAIN EXPERIENCE PITCHING TO AUDIENCES OF INDUSTRY STAKEHOLDERS AND DECISION-MAKERS. A SUBSET OF EARLIER-STAGE COMPANIES TAKE PART IN A CUSTOMIZED MENTORSHIP PROGRAM WHERE THEY ARE PAIRED WITH SENIOR LEADERS IN THE MEDICAL TECHNOLOGY (MEDTECH) INDUSTRY. ALL COHORT COMPANIES HAVE THE OPPORTUNITY TO COMPETE FOR CASH PRIZES AND IN-KIND AWARDS, WITH THE LARGEST CASH AWARDS RESERVED FOR THE EARLIER-STAGE COHORT WHERE THESE NON-DILUTIVE FINANCIAL RESOURCES CAN HAVE A SIGNIFICANT IMPACT.2. MTI HAS ATTRACTED TOP TALENT TO OVERSEE THE COMPETITION AND ACCELERATOR PROGRAMS, INCLUDING STAFF MEMBERS WITH ADVANCED DEGREES AND DOCTORATES IN FIELDS OF STUDY RELEVANT TO THE STARTUP COMPANIES THEY ASSIST. MTI STAFFERS HAVE A BROAD KNOWLEDGE AND UNDERSTANDING OF THE MEDICAL TECHNOLOGY AND LIFE SCIENCES INDUSTRIES, INCLUDING THE REGULATORY AND REIMBURSEMENT REQUIREMENTS, THE INVESTMENT ENVIRONMENT, AND THE CLINICAL AND SCIENTIFIC NEEDS FOR RESEARCH AND DEVELOPMENT. MTI ALSO DEVELOPS RELATIONSHIPS WITH HUNDREDS OF INDUSTRY EXECUTIVES, HEALTH CARE PROVIDERS, INVESTORS AND KEY OPINION LEADERS, FOR THE BENEFIT OF COMPANIES PARTICIPATING IN ITS COMPETITION AND ACCELERATOR. MTI BRINGS THESE EXPERTS TOGETHER TO SERVE AS APPLICATION REVIEWERS AND JUDGES AT REGIONAL PITCH EVENTS AND COMPETITIONS, AND THEY OFFER FEEDBACK, GUIDANCE AND MENTORSHIP TO COMPANIES THAT PROGRESS THROUGH THE PROGRAM. THESE EXPERTS VOLUNTEER THEIR TIME TO SUPPORT MTI IN ITS MISSION TO IMPROVE THE LIVES OF PATIENTS.3. THE EVENTS OF THE COMPETITION ARE CONDUCTED THROUGHOUT THE YEAR, WITH APPLICATIONS OPENING IN OCTOBER OF THE PRECEDING YEAR. THE ACCELERATOR PROGRAMS TYPICALLY RUN FROM JUNE THROUGH OCTOBER.4. THE EVENTS OF THE COMPETITION AND ACCELERATOR TAKE PLACE VIRTUALLY AND IN CITIES AROUND THE UNITED STATES, SUCH AS SAN FRANCISCO, LOS ANGELES, SAN DIEGO, RESEARCH TRIANGLE PARK, SEATTLE, CHICAGO, HOUSTON, BOSTON, MINNEAPOLIS, PHILADELPHIA, AND WASHINGTON, D.C., AND IN INTERNATIONAL LOCATIONS SUCH AS IRELAND, ISRAEL, CANADA, JAPAN, AUSTRALIA, CHINA, AND SINGAPORE. THE ACCELERATOR IS A VIRTUAL PROGRAM, LARGELY CONDUCTED VIA WEBINAR AND TELECONFERENCE, IN ADDITION TO MULTI-DAY, IN-PERSON EVENTS HELD AT ITS BEGINNING AND CONCLUSION. ALL OF THE COMPANIES SELECTED FOR MEDTECH INNOVATOR'S ANNUAL COHORT PARTICIPATE IN THE SUMMIT AND FINALS, WHICH BRING TOGETHER SENIOR LEADERSHIP FROM EACH COMPANY ALONG WITH REPRESENTATIVES FROM MEDTECH INNOVATOR'S CORPORATE PARTNERS, REPRESENTATIVES FROM FEDERAL AGENCIES THAT SUPPORT MEDICAL INNOVATION SUCH AS FDA, HHS, DOD, AND NIH, AND KEY STAKEHOLDERS SUCH AS INVESTORS AND HEALTH CARE PROVIDERS.5. MTI SEEKS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF STARTUP COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. THIS WILL BE ACCOMPLISHED BY OFFERING SUBSTANTIVE RESOURCES AND NETWORK CONNECTIONS TO THE STARTUPS LEADING UP TO AND DURING THE ACCELERATOR AS WELL AS PROVIDING DIRECT FUNDING TO SELECT COMPANIES THROUGH AWARDS IN THE COMPETITION. MTI'S ACTIVITIES FURTHER THE PUBLIC GOOD BY UNITING LEADING STAKEHOLDERS IN THE MEDTECH INNOVATION ECOSYSTEM TO SUPPORT AND GUIDE TRANSFORMATIVE EARLY-STAGE COMPANIES THAT ARE STRIVING TO SOLVE UNMET PATIENT NEEDS AND INCREASE EFFICIENCY, QUALITY, EQUITY AND VALUE IN THE HEALTH CARE SYSTEM.6. MTI IS FUNDED BY CORPORATE INDUSTRY DONORS, INCLUDING LEADING MANUFACTURERS, PRIVATE FOUNDATIONS, INVESTORS, SERVICE PROVIDERS, STATE AND FEDERAL TRADE ASSOCIATIONS, AND GRANTS FROM GOVERNMENTAL AGENCIES. MTI HOPES TO INCREASE FINANCIAL SUPPORT FROM GOVERNMENTAL AGENCIES AND PRIVATE FOUNDATIONS THAT SUPPORT HEALTH CARE INNOVATION, AS MTI PROVIDES A UNIQUE FRAMEWORK TO HELP ENSURE THAT IMPORTANT GRANT-SUPPORTED HEALTH CARE TECHNOLOGIES ACTUALLY REACH PATIENTS IN NEED.7. THERE CURRENTLY ARE NO DBAS. MTI'S WEBSITE IS HTTPS://MEDTECHINNOVATOR.ORG.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Paul Grand CEO & President | OfficerTrustee | 50 | $564,210 |
Kathryn Zavala COO | Officer | 50 | $192,500 |
Brian Benson Vp, Strategic Alliances | 50 | $138,500 | |
Christopher Martin Director | Trustee | 3 | $0 |
Scott Whitaker Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $220,800 |
All other contributions, gifts, grants, and similar amounts not included above | $4,361,314 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $4,582,114 |
Total Program Service Revenue | $0 |
Investment income | $1,089 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $4,583,203 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $425,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $265,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $872,483 |
Compensation of current officers, directors, key employees. | $87,248 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $328,526 |
Pension plan accruals and contributions | $34,265 |
Other employee benefits | $34,215 |
Payroll taxes | $57,989 |
Fees for services: Management | $0 |
Fees for services: Legal | $4,160 |
Fees for services: Accounting | $11,026 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $25,621 |
Advertising and promotion | $62,845 |
Office expenses | $55,452 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $27,166 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $13,414 |
All other expenses | $212,541 |
Total functional expenses | $2,429,703 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $2,458,181 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $3,040,151 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $5,498,332 |
Accounts payable and accrued expenses | $19,336 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $256,284 |
Total liabilities | $275,620 |
Net assets without donor restrictions | $2,091,437 |
Net assets with donor restrictions | $3,131,275 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $5,498,332 |
Over the last fiscal year, Medtech Innovator has awarded $850,000 in support to 8 organizations.
Grant Recipient | Amount |
---|---|
RHAEOS PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $350,000 |
RHAEOS PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $350,000 |
LIEF THERAPEUTICS PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $35,000 |
LIEF THERAPEUTICS PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $35,000 |
PROJECT MORAY INC PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $25,000 |
PROJECT MORAY INC PURPOSE: PRIZE MONEY FOR MEDICAL INNOVATION | $25,000 |
Over the last fiscal year, we have identified 4 grants that Medtech Innovator has recieved totaling $6,000,000.
Awarding Organization | Amount |
---|---|
Frederick Gardner Cottrell Foundation Tucson, AZ PURPOSE: CHARITABLE ENTITY SUPPORT | $2,600,000 |
Frederick Gardner Cottrell Foundation Tucson, AZ PURPOSE: CHARITABLE ENTITY SUPPORT | $2,600,000 |
Frederick Gardner Cottrell Foundation Tucson, AZ PURPOSE: CHARITABLE ENTITY SUPPORT | $400,000 |
Frederick Gardner Cottrell Foundation Tucson, AZ PURPOSE: CHARITABLE ENTITY SUPPORT | $400,000 |
Organization Name | Assets | Revenue |
---|---|---|
Live Oak A Learning Center For Children San Francisco, CA | $40,489,721 | $19,594,406 |
Biocomx Dana Point, CA | $308,692 | $15,969,949 |
Open Up Resources Menlo Park, CA | $29,661,554 | $16,279,319 |
Teach-Org Inc San Francisco, CA | $5,801,007 | $13,162,873 |
The Reason Foundation Los Angeles, CA | $15,187,245 | $16,170,727 |
San Francisco Study Center Inc San Francisco, CA | $5,230,719 | $12,852,895 |
Hoffman Institute Foundation San Rafael, CA | $2,301,194 | $11,907,757 |
Legacy Traditional School Maricopa Chandler, AZ | $18,281,409 | $11,917,984 |
Cambiar Education San Diego, CA | $11,761,927 | $15,993,046 |
Associated Students Of California State University Chico Chico, CA | $29,452,040 | $13,695,718 |
Todays Fresh Start Los Angeles, CA | $38,805,224 | $12,503,064 |
Agape Fresno, CA | $5,383,451 | $10,431,263 |